Category: News

Anvisa Bans the Selling and Advertising of Ayahuasca in Brazil

Anvisa, Brazil's health regulatory agency, banned the sale and advertising of ayahuasca-based products due to...

Chacruna Launches the Certificate in Ceremony, Ethics & Reciprocity

As psychedelics gain mainstream acceptance, ethical, legal, and safety challenges emerge. Chacruna’s 80-hour Certificate in...

After 2024, the Scenario for Psychedelic Therapies Can Only Improve

The year 2024 marked a tumultuous period, with record-breaking global heat, escalating carbon emissions, political...

Bad Trip: União do Vegetal (UDV) Ties to Far-Right Bolsonarism Resurface

The União do Vegetal (UDV), a prominent ayahuasca group in Brazil, faces scrutiny for leaders'...

Symposium in Brazil Debates Psychedelics at a Political Crossroads

In Brazil, two recent events highlighted challenges and opportunities for psychedelic therapies in mental health....

Conference in Rio Defends Psychedelics in Public Health

The II Brazilian Congress on Psychedelics, held at IPUB-UFRJ, focused on integrating psychedelics into Brazil's...

Psychedelic Courses in Brazil Have High Demand and Many Challenges

Science in Brazil faces many challenges. such as funding shortages, that affect psychedelic research. Postgraduate...

Santo Daime ‘Padrinho’ in Rio Faces Accusation of Sexual Harassment

The Eclectic Church of the Fluent Universal Light (ICEFLU), the main Santo Daime organization in...

The FDA’s Rejection on MDMA-Assisted Therapy: What is Next for the Psychedelic Movement?

The FDA's call for another phase 3 study of MDMA-Assisted Therapy delays approval, revealing biomedical...

Will MDMA win FDA Approval?

Recent advisory groups ICER and AdComm have recommended against FDA approval of MDMA for medical...
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
page
product
tribe_events
resource